IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, and bacterial diseases and of fungal infections

US6210661A · kind A · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Karlheinz Enssle · Marburg, DE
• Roland Kurrle · Frankfurt am Main, DE
• Leander Lauffer · Gladenbach, DE
• Friedrich-Robert Seiler · Marburg, DE

Key dates

• Filing date: Aug 5, 1996
• Grant date: Apr 3, 2001
• Expiry date: Aug 5, 2016

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections. The invention relates to the il-4 receptor or variants thereof for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections.